Clinical trial
Study of the Impact of a Gait Exoskeleton on the Quality of Life of Patients With Spinal Muscular Atrophy
NCT05416034 is registered in ClinicalTrials.gov with MarsiBionics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Impact of a Gait Exoskeleton on the Quality of Life of Patients With Spinal Muscular Atrophy
- Lead sponsor
- MarsiBionics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2017
- Completion date
- August 31, 2018
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spinal muscular atrophy type ii